- Tytuł:
- Real-World Use of Fedratinib for Myelofibrosis Following Prior Ruxolitinib Failure: Patient Characteristics, Treatment Patterns, and Clinical Outcomes
- Autorzy:
- Źródło:
- In Clinical Lymphoma, Myeloma and Leukemia February 2024 24(2):122-132
Czasopismo naukowe